°Ç¼±¼º °üÀý¿° Ä¡·á ½ÃÀå º¸°í¼­ : ¾àÁ¦ À¯Çüº°, À¯Çüº°, Åõ¿© °æ·Îº°, À¯Åë ä³Îº°, Áö¿ªº°(2024-2032³â)
Psoriatic Arthritis Treatment Market Report by Drug Type (NSAIDs, DMARDs, Biologics, and Others), Type, Route of Administration, Distribution Channel, and Region 2024-2032
»óǰÄÚµå : 1561466
¸®¼­Ä¡»ç : IMARC Group
¹ßÇàÀÏ : 2024³â 09¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 143 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 2,999 £Ü 4,339,000
PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 3,999 £Ü 5,786,000
PDF & Excel (5 User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,999 £Ü 7,233,000
PDF & Excel (Corporate License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ °Ç¼±¼º °üÀý¿° Ä¡·á ½ÃÀå ±Ô¸ð´Â 2023³â 97¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. IMARC GroupÀº ÇâÈÄ 2024³âºÎÅÍ 2032³â±îÁö 9.2%ÀÇ ¼ºÀå·ü(CAGR)À» º¸ÀÏ Àü¸ÁÀ̸ç, 2032³â±îÁö 218¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù.

°Ç¼±¼º °üÀý¿°Àº ¸é¿ª°è°¡ °üÀýÀ» °ø°ÝÇÏ¿© ¿°ÁõÀ» ÀÏÀ¸Å°´Â ÀÚ°¡¸é¿ª ÁúȯÀÔ´Ï´Ù. Ä¡·á ¿É¼ÇÀº º×±â¿Í ¿°ÁõÀ» ¾ïÁ¦ÇÏ´Â ³»º¹Á¦¿¡¼­ ƯÁ¤ ¸é¿ª°è¸¦ Ç¥ÀûÀ¸·Î ÇÏ´Â »ý¹°ÇÐÀû Ä¡·á¿¡ À̸£±â±îÁö ´Ù¾çÇÕ´Ï´Ù. ÅëÁõ, º×±â, °æÁ÷ Á¤µµ¿¡ µû¶ó Ä¡·á°¡ ÀÌ·ç¾îÁý´Ï´Ù. ÇöÀç ÁÖ¿ä ±â¾÷µéÀº Áúº´ ÁøÇàÀ» ¸·°í ÅëÁõÀ» ¿ÏÈ­ÇÏ°í °üÀýÀ» º¸È£ÇÏ¸ç ¿òÁ÷ÀÌ´Â Áö¿ªÀ» À¯ÁöÇÏ´Â »õ·Î¿î Ä¡·á¹ýÀ» µµÀÔÇϰí ÀÖ½À´Ï´Ù. ÀÌ ¹æ¹ýÀº ±ÙÀ°°ú °üÀýÀ» °­È­Çϰí Àü¹ÝÀûÀÎ ¾ÈÁ¤¼ºÀ» Çâ»ó½ÃŰ´Â ¹°¸®Ä¡·á¹ý°ú °áÇÕÇÒ ¼ö ÀÖ½À´Ï´Ù.

°Ç¼±¼º °üÀý¿° Ä¡·á ½ÃÀå µ¿Çâ :

°Ç¼± ÁúȯÀº °Ç¼±¼º °üÀý¿°ÀÇ ÁÖ¿ä À§Çè ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ±× °á°ú °¨¿°, ½ºÆ®·¹½º, ºñ¸¸, ÇǺΠ¼Õ»ó, ¾ËÄÚ¿Ã ³²¿ë, ºñŸ¹Î °áÇÌ µîÀ¸·Î ÀÎÇÑ °Ç¼± ÁúȯÀÇ À¯º´·ü Áõ°¡°¡ ½ÃÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ¿äÀÎ Áß Çϳª°¡ µÇ¾ú½À´Ï´Ù. °Ô´Ù°¡ °Ç¼±¼º °üÀý¿°Àº 30¼¼¿¡¼­ 50¼¼ »çÀÌ¿¡¼­ °¡Àå ÈçÇÏ°Ô ¹ß»ýÇϱ⠶§¹®¿¡ ¼¼°è ¼ºÀÎ Àα¸ Áõ°¡°¡ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. À̿ʹ º°µµ·Î, °Ç¼±¼º °üÀý¿°À» ¾Î´Â ¼Ò¾Æ´Â ¾È±¸ÀÇ ÁßÃþ Á¶Á÷À» ħ¹üÇÏ´Â Æ÷µµ¸·¿°À» ÀÏÀ¸Å³ °¡´É¼ºÀÌ ³ô½À´Ï´Ù. À̰ÍÀº ¾Æµ¿ÀÇ °Ç°­¿¡ ´ëÇÑ ºÎ¸ðÀÇ °ü½É Áõ°¡¿Í ÇÔ²² ¼¼°èÀÇ °Ç¼±¼º °üÀý¿° Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä¸¦ ȯ±âÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Á¶±â Áø´Ü°ú Á¶±â Ä¡·á·Î ÀÎÇÑ ½É°¢ÇÑ ¼Õ»óÀÇ ¿¹¹æ°ú °°Àº ÀÌÁ¡¿¡ ´ëÇÑ ÀǽÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ½ÃÀå ¼ºÀåÀÌ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù. ±âŸ, °³ÀÎÀÇ °¡Ã³ºÐ¼Òµæ Áõ°¡, ÀÇ·á½Ã¼³ÀÇ °³¼±, °³ÀÎÀÇ °Ç°­ÀÇ½Ä Áõ°¡ µîÀÌ ½É°¢ÇÑ Áõ»ó°ú ½Î¿ì±â À§ÇÑ ½Å±ÔÀÇ °Ç¼±¼º °üÀý¿° Ä¡·áÁ¦¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ º¸°í¼­¿¡¼­ ´Ù·ç´Â ÁÖ¿ä Áú¹®

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§ ¹× Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼­¹®

Á¦5Àå ¼¼°èÀÇ °Ç¼±¼º °üÀý¿° Ä¡·á ½ÃÀå

Á¦6Àå ½ÃÀå ³»¿ª : ¾àÁ¦ À¯Çüº°

Á¦7Àå ½ÃÀå ³»¿ª : À¯Çüº°

Á¦8Àå ½ÃÀå ³»¿ª : Åõ¿© °æ·Îº°

Á¦9Àå ½ÃÀå ³»¿ª : À¯Åë ä³Îº°

Á¦10Àå ½ÃÀå ³»¿ª : Áö¿ªº°

Á¦11Àå SWOT ºÐ¼®

Á¦12Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦13Àå Porter's Five Forces ºÐ¼®

Á¦14Àå °¡°Ý ºÐ¼®

Á¦15Àå °æÀï ±¸µµ

AJY
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global psoriatic arthritis treatment market size reached US$ 9.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 21.8 Billion by 2032, exhibiting a growth rate (CAGR) of 9.2% during 2024-2032.

Psoriatic arthritis is an autoimmune disorder wherein the immune system attacks the joints and causes inflammation. Its treatment options vary from oral medications that reduce swelling and inflammation to biological therapies that target the specific immune system. It is treated as per the level of pain, swelling, and stiffness. At present, key players are introducing new treatment methods that help prevent disease progression, reduce pain, protect joints, and preserve the range of motion. These methods can be combined with physical therapy to strengthen muscles and joints and increase overall stability.

Psoriatic Arthritis Treatment Market Trends:

Psoriasis disease is one of the major risk factors for psoriatic arthritis. As a result, the increasing prevalence of psoriasis disease due to infection, stress, obesity, skin injuries, alcohol abuse, and vitamin deficiencies represents one of the primary factors influencing the market positively. Moreover, as psoriatic arthritis occurs most commonly among individuals between the ages of 30 and 50, the rising adult population worldwide is contributing to the market growth. Apart from this, children with psoriatic arthritis are more likely to develop uveitis that affects the middle layer of tissue in the eyewall. This, in confluence with the growing concerns among parents about the health of their children, is catalyzing the demand for psoriatic arthritis treatment across the globe. In addition, the rising awareness about the benefits of early diagnosis and treatment of psoriatic arthritis, such as preventing serious damages, is bolstering the market growth. Other factors, such as inflating disposable income of individuals, improvement in healthcare facilities, and the growing health awareness among individuals, are anticipated to drive the demand for novel psoriatic arthritis treatment to combat severe symptoms.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global psoriatic arthritis treatment market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on drug type, type, route of administration and distribution channel.

Breakup by Drug Type:

Breakup by Type:

Breakup by Route of Administration:

Breakup by Distribution Channel:

Breakup by Region:

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Amgen Inc., Amneal Pharmaceuticals LLC, AstraZeneca plc, Bristol-Myers Squibb Company, Eisai Co. Ltd., Eli Lilly and Company, Johnson & Johnson Service ltd., Novartis AG, Pfizer Inc., Samsung Biologics and UCB S.A.

Key Questions Answered in This Report:

Table of Contents

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global Psoriatic Arthritis Treatment Market

6 Market Breakup by Drug Type

7 Market Breakup by Type

8 Market Breakup by Route of Administration

9 Market Breakup by Distribution Channel

10 Market Breakup by Region

11 SWOT Analysis

12 Value Chain Analysis

13 Porters Five Forces Analysis

14 Price Analysis

15 Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â